Available datapackage for study 'The Effect of Subcutaneous r-HuEPO in Patients With Chronic Lymphocytic Leukemia'

The purpose of this study is to evaluate the effect of treatment with epoetin alfa versus placebo on the percentage of red blood cells in anemic patients with chronic lymphocytic (white blood cell) leukemia and its effect on the patients' quality-of-life. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.